This month, some of our East Coast-based Geronites volunteered at SAVE A Friend to Homeless Animals, a shelter in the Greater Princeton area. It was a great opportunity for the animal lovers on our team to play a role in helping these animals find their forever homes. Together, we made cat and dog beds, cleaned, and networked with our colleagues. Thank you to the team for their volunteer efforts, to Executive Director of Commercial Operations Jason Grossman for organizing, and to SAVE!
Geron Corporation
Biotechnology Research
Foster City, California 12,964 followers
Changing lives by changing the course of blood cancer.
About us
Powered by pioneering science, grounded in world-class expertise, and driven by purpose, Geron is a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer. Our first-in-class telomerase inhibitor is FDA-approved for the treatment of adults with low-to-intermediate-1 risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia requiring four or more red blood cell units over eight weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESAs). We are also conducting a pivotal Phase 3 clinical trial in JAK-inhibitor relapsed/refractory myelofibrosis (R/R MF), as well as studies in other hematologic malignancies. Inhibiting telomerase activity, which is increased in malignant stem and progenitor cells in the bone marrow, aims to potentially reduce proliferation and induce death of malignant cells. To learn more, visit www.geron.com. Geron’s Community Guidelines: https://www.geron.com/CommunityGuidelines/
- Website
-
http://www.geron.com
External link for Geron Corporation
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Foster City, California
- Type
- Public Company
- Founded
- 1992
- Specialties
- Oncology, Hematologic Malignancies, and Telomerase Inhibition
Locations
-
919 E Hillsdale Blvd
Foster City, California 94404, US
Employees at Geron Corporation
Updates
-
We are proud to share that Geron has been named one of the San Francisco Chronicle’s 2024 Top Workplaces! Our mission can only be accomplished through the culture and values we embody as a team. We recognize and embrace the unique strengths of our team members and the impact and contributions of each employee. Thank you for your dedication and for sharing your talents with us. Learn more: https://lnkd.in/e7eW5ipp
-
Nobel Prize-winning science was our beginning. The belief in the potential of telomerase inhibition started our journey. Learn more about Geron’s dedication to changing the course of #BloodCancer: https://lnkd.in/ecxHSVKg
-
We have released our Q2 2024 financial results and business updates. Learn more: https://bit.ly/3SHdAcP.
-
We plan to release our Q2 2024 financial results and business highlights on August 8 at 8 a.m. ET. Learn more: https://lnkd.in/dCP_jn97
-
Today, we announced that the National Comprehensive Cancer Network® (NCCN®) updated their Clinical Practice Guidelines in Oncology for Myelodysplastic Syndromes (MDS) to include our medicine for the treatment of symptomatic anemia in patients with lower-risk #MDS. Learn more: https://lnkd.in/eFkc7tz8
-
Meet Annie Brown, Key Account Manager. Annie, who says she has a passion for hematology, has been in the industry for more than 20 years. During that time, she has been fortunate enough to work on many newly launched products. “My role at Geron allows me to work more collaboratively with a diverse group of talented individuals across departments towards a common goal to deliver innovative therapies to patients. The small but mighty team that is Geron is extremely impressive across the entire organization, and I knew I wanted to be part of that!”
-
For the past three years, Geron has been proud to be a National Sponsor for #MoveForMDS walks, organized by MDS Foundation, Inc., which supports efforts to unite communities, drive awareness and accelerate research for myelodysplastic syndromes (#MDS). The next walk is on August 25 in Chicago! Learn more and sign up for an upcoming walk: https://moveformds.org/
-
Powered by pioneering science, grounded in world-class expertise, and driven by purpose, Geron aims to change lives by changing the course of #BloodCancer. Learn more about our story: https://lnkd.in/ecdpB8p2
-
Meet Leslie Cherette, Director, CMC Program Management. Leslie’s childhood passion for science led her to a career in STEM. She says Geron provided her the opportunity to make a more tangible impact in the patient community, particularly in areas with unmet need. This #Juneteenth, Leslie says she is proud to be the first African American woman in her program management position at Geron, and of her work in Geron’s recent FDA approval. “I am inspired by a dedicated and driven group of people who motivate me to believe that we can accomplish anything, including bringing this therapy, and others like it, to some of the most underserved patient populations.”